CY
CYduct Diagnostics, Inc.
CYDX · OTC
$0.50 +0.00% (+$0.00)
1M -59.68%
Market Cap $2.62M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0.33
34.0% downside
Current Price
$0.5
Undervalued Fair Value Overvalued
According to Bulios Fair Price, CYDX is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Moderate
5/9Valuation
0 /100
Expensive P/S 37.24x
P/FCF 228.06x
P/E N/A
Growth
0 /100
Declining Rev. growth 16.14%
EPS growth N/A
Book val. growth N/A
Profitability
48 /100
Moderate Gross margin 62.32%
FCF margin 16.33%
Net margin 294.73%
Quality
79 /100
Excellent ROIC 56.60%
Asset turnover 2.34x
ROA 690.85%
Debt
0 /100
High Current ratio 0.07x
Int. coverage -3.74x
Debt/Equity N/A
Stability
57 /100
Moderate Beta -0.93x
Profitable years 0
Rev. volatility 14.41%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about CYDX
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Dom L. Gatto
Employees
3
Headquarters
Westport